Treatment of anorexia and malnutrition in peritoneal dialysis patients with megestrol acetate.

@article{Costero2004TreatmentOA,
  title={Treatment of anorexia and malnutrition in peritoneal dialysis patients with megestrol acetate.},
  author={Olga Costero and Mar{\'i}a Auxiliadora Bajo and Gloria del Peso and Francisco Gil and Abelardo I Aguilera and Silvia Ros and Covadonga Hev{\'i}a and Rafael Selgas},
  journal={Advances in peritoneal dialysis. Conference on Peritoneal Dialysis},
  year={2004},
  volume={20},
  pages={209-12}
}
Anorexia and malnutrition are common complications and powerful predictors of morbidity and mortality in peritoneal dialysis (PD) patients. Megestrol acetate (MA) is a progestogen that has been demonstrated to increase appetite and weight in patients with cancer or acquired immunodeficiency syndrome. To determine whether MA might benefit PD patients, we treated 32 patients with 160 mg MA daily. Treatment lasted a mean of 5.93 +/- 5.12 months (range: 1 - 23 months). In 68.8% of the patients… CONTINUE READING

Similar Papers

Loading similar papers…